Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
Total Results: 593 Videos
MrWhy.com » Videos » Www.Ecancer.Tv -
Categories
Science (593)
Page: 12 of 30Previous Page8910111213141516Next Page
Dr Gregory Beatty - University of Pennsylvania,  USA Dr Gregory Beatty - University of Pennsylvania, USA
Channel: www.ecancer.tv
Length: 0
Date: July 20, 2010
Dr Beatty discusses his research into the use of the CD40 agonist monoclonal antibody CP-870,893 to treat pancreatic cancer. When used in conjuncti...
Prof Gilles Salles - Universite Claude Bernard Lyon,  France Prof Gilles Salles - Universite Claude Bernard Lyon, France
Channel: www.ecancer.tv
Length: 0
Date: July 20, 2010
Prof Salles discusses the results he is presenting at ASCO 2010 from the PRIMA study. This trial assessed the efficacy of rituximab as a maintenanc...
Dr Keith Stewart - Mayo Clinic,  Arizona, USA Dr Keith Stewart - Mayo Clinic, Arizona, USA
Channel: www.ecancer.tv
Length: 0
Date: July 16, 2010
Dr Stewart discusses results of Phase I and Phase II trials of carfilzomib, a next generation proteasome inhibitor, which has a different binding ...
Dr Evangelos Terpos - University of Athens,  Greece Dr Evangelos Terpos - University of Athens, Greece
Channel: www.ecancer.tv
Length: 0
Date: July 16, 2010
Dr Evangelos Terpos, speaking at EHA 2010, discusses bone disease in multiple myeloma and the targeted therapies for treatment and prevention of s...
Dr Elisabeth Pitterman - Hanusch Hospital,  Vienna, Austria Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria
Channel: www.ecancer.tv
Length: 0
Date: July 15, 2010
Dr Elisabeth Pitterman, an Austrian delegate at ASCO Chicago 2010, gives her views and highlights of the joint ASCO-ASH education session. (In Ger...
Dr Karim Fizazi - Institut Gustave Roussy,  France Dr Karim Fizazi - Institut Gustave Roussy, France
Channel: www.ecancer.tv
Length: 0
Date: July 08, 2010
Dr Karim Fizazi discusses his phase III trial which compared the efficacy of denosumab with zoledronic acid in patients with matastatic castration-...
Dr Brigitte Rack,  Munich University Hopsital, Germany Dr Brigitte Rack, Munich University Hopsital, Germany
Channel: www.ecancer.tv
Length: 0
Date: July 08, 2010
Data from the SUCCESS trial, presented at ASCO, looked at circulating tumour cells in primary breast cancer.  Dr. Brigitte Rack ta...
Professor Bruce Cheson,  Lombardi Comprehensive Cancer Center, Washington DC, USA Professor Bruce Cheson, Lombardi Comprehensive Cancer Center, Washington DC, USA
Channel: www.ecancer.tv
Length: 0
Date: July 06, 2010
Data presented at the Joint ASH/ASCO Educational Meeting suggested good results for new frontline treatments for various lymphomas. Prof. Bruce Che...
Prof Gordon McVie,  Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Boccadoro, Prof Pierre Fenaux Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Boccadoro, Prof Pierre Fenaux
Channel: www.ecancer.tv
Length: 0
Date: June 30, 2010
Healthcare experts discuss the care of the elderly in haemato-oncology, looking at the current situation across Europe and what is needed to chang...
Professor Chris Twelves - St James’s Hospital,  Leeds, UK Professor Chris Twelves - St James’s Hospital, Leeds, UK
Channel: www.ecancer.tv
Length: 0
Date: June 30, 2010
A new study presented at ASCO has found that eribulin can extend the survival rates of women with locally recurrent or metastatic breast cancer in ...
Dr Thierry Le Chevalier - Gustave-Roussy Institute,  Villejuif, France Dr Thierry Le Chevalier - Gustave-Roussy Institute, Villejuif, France
Channel: www.ecancer.tv
Length: 0
Date: June 30, 2010
Dr Le Chevalier speaks about the work carried out at the Gustave-Roussy Institute and the difficulties faced when treating lung cancer. In order to...
Prof David Cameron,  Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem
Channel: www.ecancer.tv
Length: 0
Date: June 30, 2010
Prof David Cameron chairs a round table debate on clinical trial design and comparator arms. The discussion examines issues such as the need to fas...
Prof David Cameron,  Prof Patrick Schöffski, Prof Hilary Calvert Prof David Cameron, Prof Patrick Schöffski, Prof Hilary Calvert
Channel: www.ecancer.tv
Length: 0
Date: June 30, 2010
This roundtable discussion looks at the advantages and disadvantages of overall survival and progression free survival as primary end points of cli...
Prof Jacek Jassem - University of Gdansk,  Poland Prof Jacek Jassem - University of Gdansk, Poland
Channel: www.ecancer.tv
Length: 0
Date: June 29, 2010
Prof Jassem talks about advances in the treatment of lung cancer and the number of options that are now available to patients. More effective and s...
Professor Ignace Vergote - Catholic University of Leuven,  Belgium Professor Ignace Vergote - Catholic University of Leuven, Belgium
Channel: www.ecancer.tv
Length: 0
Date: June 25, 2010
Professor Ignace Vergote speaks about his research into NKTR-102, a new drug for treating women with platinum-resistant/refractory ovarian cancer....
Professor Richard Sullivan,  King’s College London, UK Professor Richard Sullivan, King’s College London, UK
Channel: www.ecancer.tv
Length: 0
Date: June 25, 2010
Prof Richard Sullivan talks about a collaborative initiative to push the issue of cancer and the elderly up the social-political agenda. He suggest...
Prof Gareth Morgan,  Institute of Cancer Research, Sutton, UK Prof Gareth Morgan, Institute of Cancer Research, Sutton, UK
Channel: www.ecancer.tv
Length: 0
Date: June 25, 2010
Results of a multiple myeloma study, presented at ASCO, has found that zoledronic acid (Zometa) reduces the incidence of skeletal related events a...
Dr Mathias Rummel - University Hospital,  Giessen, Germany Dr Mathias Rummel - University Hospital, Giessen, Germany
Channel: www.ecancer.tv
Length: 0
Date: June 25, 2010
Although it is known that rituximab (trade name Rituxan) should be used in combination with chemotherapy to treat patients with indolent lymphoma d...
Professor Jesús San-Miguel,  University Hospital of Salamanca, Spain Professor Jesús San-Miguel, University Hospital of Salamanca, Spain
Channel: www.ecancer.tv
Length: 0
Date: June 25, 2010
Prof Jesús San-Miguel, speaking to Prof Gordon McVie, talks about the progression in myeloma survival rates and the contributing factors. ...
Jan Geissler,  Director, European Cancer Patient Coalition Jan Geissler, Director, European Cancer Patient Coalition
Channel: www.ecancer.tv
Length: 0
Date: June 25, 2010
Jan Geissler talks about the issue of ageism in cancer treatment, discussing the reasons why older patients don’t appear to receive as good a trea...
Page: 12 of 30Previous Page8910111213141516Next Page
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.